Skip to main content

Advances in Therapy OnlineFirst articles

Open Access 20.04.2024 | Commentary

Real-World Data on Therapies for Relapsed or Refractory Multiple Myeloma: Key Data from ASH 2023—A Podcast

Immunotherapies have significantly improved outcomes in patients with multiple myeloma yet maintaining a durable response in heavily pretreated patients remains challenging. Therapies that target B cell maturation antigen (BCMA) provide additional …

verfasst von:
Luciano J. Costa, Paula Rodriguez-Otero

Open Access 20.04.2024 | Brief Report

Efgartigimod and Ravulizumab for Treating Acetylcholine Receptor Auto-antibody-Positive (AChR-Ab+) Generalized Myasthenia Gravis: Indirect Treatment Comparison

Generalized myasthenia gravis (gMG) is a rare, chronic, neuromuscular autoimmune disease, mediated by pathogenic immunoglobulin auto-antibodies targeting the neuromuscular junction [ 1 ]. gMG is a debilitating disease that negatively impacts …

verfasst von:
Cécile van Steen, Lorenzo Celico, Erik Spaepen, Tim Hagenacker, Sven G. Meuth, Tobias Ruck, A. Gordon Smith, Danielle H. Bodicoat, Maria de Francesco, Sergio Iannazzo

20.04.2024 | Review

Primary Management of Operable Locally Advanced Oral Cavity Squamous Cell Carcinoma: Current Concepts and Strategies

Despite increased oral screening programs and advances in diagnostic modalities in detecting oral cancers at an early stage, a disproportionately high number of patients are still diagnosed in advanced stages [ 1 – 3 ]. Nearly 55% of patients with …

verfasst von:
Ameya A. Asarkar, Brent A. Chang, Remco de Bree, Luiz P. Kowalski, Orlando Guntinas-Lichius, Patrick J. Bradley, Pim de Graaf, Primož Strojan, Karthik N. Rao, Antti A. Mäkitie, Fernando López, Alessandra Rinaldo, Carsten Palme, Eric M. Genden, Alvaro Sanabria, Juan P. Rodrigo, Alfio Ferlito

Open Access 15.04.2024 | Original Research

Treatment-Free Interval: A Novel Approach to Assessing Real-World Treatment Effectiveness and Economic Impact Among Patients with Irritable Bowel Syndrome with Diarrhea

Irritable bowel syndrome (IBS) with diarrhea (IBS-D) is a common, chronic, relapsing, and potentially severe disorder of gut–brain interaction (DGBI) characterized by troublesome symptoms such as abdominal pain, diarrhea, fecal urgency, and …

verfasst von:
Brian E. Lacy, Patrick Gagnon-Sanschagrin, Zeev Heimanson, Rebecca Bungay, Remi Bellefleur, Annie Guérin, Brock Bumpass, Danellys Borroto, George Joseph, Ankur A. Dashputre

Open Access 15.04.2024 | Original Research

Comparative Effectiveness of Valoctocogene Roxaparvovec and Prophylactic Factor VIII Replacement in Severe Hemophilia A

Hemophilia A (HA), a rare X-linked recessive bleeding disorder caused by a deficiency of coagulation factor VIII (FVIII) protein [ 1 ], affects approximately 17.1 per 100,000 male individuals worldwide [ 2 ]. Standard of care (SOC) for individuals …

verfasst von:
Johannes Oldenburg, Herve Chambost, Hai Liu, Charles Hawes, Xiaojun You, Xinqun Yang, Vanessa Newman, Tara M. Robinson, Anthony J. Hatswell, David Hinds, Sandra Santos, Margareth Ozelo

15.04.2024 | Study Protocol

Rationale and Design of the IMPROVE Trial: A Multicenter, Randomized, Controlled, Open-label, Blinded-endpoint Trial Assessing the Efficacy of Remote Ischemic Conditioning in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting

Coronary artery bypass grafting (CABG) is an important revascularization treatment for patients with coronary artery disease [ 1 ]. Previously, cardiopulmonary bypass (CPB) was required during the CABG (on-pump CABG) and might result in …

verfasst von:
Yang Yan, Changying Zhao, Jialan Niu, Pengyun Yan, Jing Li, Duolao Wang, Guoliang Li

Open Access 15.04.2024 | Review

Real-World Effectiveness and Safety of Ramucirumab as a Second-Line Treatment for Patients with Unresectable Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma in Japan and South Korea: A Systematic Literature Review

Gastric cancer is the fifth most common malignancy and the fourth leading cause of cancer death worldwide, with 1.09 million new cases and 0.77 million deaths in 2020 [ 1 ]. There is a heavy burden of gastric cancer in Eastern Asia, which has the …

verfasst von:
Xiaotian Zhang, Li Zhou, Chan Zhou, Lin Shen

Open Access 15.04.2024 | Original Research

Real-World Treatment Patterns and Healthcare Resource Use for Ulcerative Colitis and Crohn’s Disease in Italy

Inflammatory bowel disease (IBD) comprises ulcerative colitis (UC) and Crohn’s disease (CD), both of which are chronic, relapsing and debilitating conditions with a disease course that may range in severity and progression [ 1 – 3 ]. In Italy, the …

verfasst von:
Melania Dovizio, Susanne Hartz, Carlotta Buzzoni, Isabel Redondo, Marijana Nedeljkovic Protic, Domenico Birra, Valentina Perrone, Chiara Veronesi, Luca Degli Esposti, Alessandro Armuzzi

Open Access 15.04.2024 | Original Research

Reduction in Diabetes-Related Hospitalizations and Medical Costs After Dexcom G6 Continuous Glucose Monitor Initiation in People with Type 2 Diabetes Using Intensive Insulin Therapy

Type 2 diabetes (T2D) is a significant health concern in the USA with > 30 million adults diagnosed with the disease [ 1 ]. The already high prevalence of T2D is expected to increase by almost 50% globally by 2045 [ 2 ]. About one in four people …

verfasst von:
Katia L. Hannah, Poorva M. Nemlekar, Courtney R. Green, Gregory J. Norman

Open Access 10.04.2024 | Correction

Correction to: Real-World Safety and Effectiveness of an 8-Week Regimen of Glecaprevir/Pibrentasvir in Patients with Hepatitis C and Cirrhosis

verfasst von:
Mei Lu, Loralee B. Rupp, Christina Melkonian, Sheri Trudeau, Yihe G. Daida, Mark A. Schmidt, Stuart C. Gordon

Open Access 04.04.2024 | Original Research

Safety and Efficacy of Pegcetacoplan in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria over 48 Weeks: 307 Open-Label Extension Study

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, life-threatening disease characterized by complement-mediated hemolysis and thrombosis [ 1 ]. Patients with PNH have an acquired mutation in PIG-A , leading to the lack of …

verfasst von:
Christopher J. Patriquin, Andrija Bogdanovic, Morag Griffin, Richard J. Kelly, Jaroslaw P. Maciejewski, Brian Mulherin, Régis Peffault de Latour, Alexander Röth, Veena Selvaratnam, Jeffrey Szer, Mohammed Al-Adhami, Regina Horneff, Lisa Tan, Michael Yeh, Jens Panse

Open Access 04.04.2024 | Original Research

Exploring the Content Validity of the Unified Wilson Disease Rating Scale: Insights from Qualitative Research

Wilson disease (WD) is an inherited autosomal recessive metabolic disorder of impaired copper transport. WD causes an accumulation of copper in multiple organs, namely the liver and brain, resulting in a range of neurological, psychiatric, and …

verfasst von:
Stella Karantzoulis, Karli Heuer, Nicole Sparling, Brian Meltzer, Megan Teynor

Open Access 01.04.2024 | Original Research

Perceptions and Experiences of People with Obesity and Type 2 Diabetes Around Appetite and Eating Behaviors: A Qualitative Study

According to the Centers for Disease Control and Prevention (CDC), the estimated prevalence of obesity in adults in the USA in 2020 was nearly 42% [ 1 ]. Obesity or overweight (defined as accumulation of excess fat that is detrimental to health) …

verfasst von:
Jiat Ling Poon, Louise OHara, Helen Kendal, Kate Sully, Margaret Guy, Helena Bradley, Chloe Tolley, Brad Mason

Open Access 30.03.2024 | Original Research

Modelling Treatment Sequences in Immunology: Optimizing Patient Outcomes

The landscape of immune-mediated disorders includes dermatological, gastrointestinal, and rheumatological diseases. Patients with these disorders can suffer from disabling symptoms and significant complications; there remains significant unmet …

verfasst von:
Rose J. Hart, Fareen Hassan, Sarah Alulis, Karl W. Patterson, Jennifer Norma Barthelmes, Jennifer H. Boer, Dawn Lee

Open Access 27.03.2024 | Original Research

Pharmacological Basis of Differences in Dose Response, Dose Equivalence, and Duration of Action of Inhaled Corticosteroids

Asthma treatment guidelines and the Global Initiative for Asthma strategy document classify inhaled corticosteroid (ICS) regimens via low-, medium-, and high-dose categories [ 1 , 2 ], often with reference to the now discontinued beclomethasone …

verfasst von:
Peter T. Daley-Yates, Bhumika Aggarwal, Maximilian Plank

23.03.2024 | Original Research

Assessing the Effects of Metabolic Disruption, Body Mass Index and Inflammation on Depressive Symptoms in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine

Inflammatory and metabolic comorbidities (e.g., central and peripheral inflammation, obesity, insulin resistance, and diabetes mellitus) frequently co-occur and share pathophysiologic features with chronic psychiatric disorders such as major …

verfasst von:
Angela T. H. Kwan, Ziji Guo, Felicia Ceban, Gia Han Le, Sabrina Wong, Kayla M. Teopiz, Taeho Greg Rhee, Roger Ho, Joshua D. Di Vincenzo, Sebastian Badulescu, Shakila Meshkat, Bing Cao, Joshua D. Rosenblat, Giacomo d’Andrea, Donovan A. Dev, Lee Phan, Mehala Subramaniapillai, Roger S. McIntyre

Open Access 23.03.2024 | Brief Report

Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims Analysis

Overactive bladder (OAB) is a chronic disorder that affects approximately 30% of adults ≥ 65 years old, and the prevalence increases with age [ 1 , 2 ]. The symptoms of OAB include urinary urgency, increased daytime urinary frequency, and/or …

verfasst von:
Benjamin Chastek, Adam Carrera, Christina Landis, Daniel Snyder, Laleh Abedinzadeh, Tim Bancroft, Jeffrey Nesheim, Michael Kennelly, David Staskin

Open Access 21.03.2024 | Review

Clinical Management of Patients with Non-Small Cell Lung Cancer, Brain Metastases, and Actionable Genomic Alterations: A Systematic Literature Review

Lung cancer is the most common cause of cancer mortality worldwide, with an estimated 1.80 million deaths annually [ 1 ]. Non-small cell lung cancer (NSCLC) accounts for 81% of all lung cancers [ 2 ]. More than half of newly diagnosed patients with …

verfasst von:
Mustafa Khasraw, Priyanka Yalamanchili, Anu Santhanagopal, Chuntao Wu, Maribel Salas, Jie Meng, Maha Karnoub, Stephen Esker, Enriqueta Felip

Open Access 21.03.2024 | Review

‘Totality of Evidence’ Approach in the Development of GP2017, an Approved Adalimumab Biosimilar

Humira ® (Adalimumab; AbbVie Inc., North Chicago, IL, USA [REF-ADL]) is a fully human immunoglobulin G1 (IgG1) monoclonal antibody targeting tumor necrosis factor alpha (TNF-α) [ 1 , 2 ]. Adalimumab is highly specific for TNF-α, binding to no other …

verfasst von:
Norman Gaylis, Charlotte Both, Lena Lemke, Oliver von Richter, Paul Yamauchi

Open Access 21.03.2024 | Original Research

Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study

This article is published with digital features, including a graphical abstract, to facilitate understanding of the article. To view digital features for this article, go to https://doi.org/10.6084/m9.figshare.25273465 .

verfasst von:
Eun-Gyoung Hong, Kyung-Wan Min, Jung Soo Lim, Kyu-Jeung Ahn, Chul Woo Ahn, Jae-Myung Yu, Hye Soon Kim, Hyun Jin Kim, Won Kim, Dong Han Kim, Hak Chul Jang